AN EVALUATION OF THE MARMOSET CALLITHRIX-JACCHUS (SAGUI) AS AN EXPERIMENTAL-MODEL FOR THE DYSLIPOPROTEINEMIA OF HUMAN SCHISTOSOMIASIS-MANSONI

Citation
Vlm. Lima et al., AN EVALUATION OF THE MARMOSET CALLITHRIX-JACCHUS (SAGUI) AS AN EXPERIMENTAL-MODEL FOR THE DYSLIPOPROTEINEMIA OF HUMAN SCHISTOSOMIASIS-MANSONI, Biochimica et biophysica acta, L. Lipids and lipid metabolism, 1393(2-3), 1998, pp. 235-243
Citations number
45
Categorie Soggetti
Biology,Biophysics
ISSN journal
00052760
Volume
1393
Issue
2-3
Year of publication
1998
Pages
235 - 243
Database
ISI
SICI code
0005-2760(1998)1393:2-3<235:AEOTMC>2.0.ZU;2-G
Abstract
Human infection with the parasite Schistosoma mansoni is a relatively common occurrence in regions of South America and is associated with l iver dysfunction and dyslipoproteinemia. Specifically, the activity of plasma lecithin :cholesterol acyltransferase (LCAT) activity is reduc ed, the concentration of plasma cholesterol esters falls, phospholipid concentrations are elevated and erythrocyte membranes become choleste rol enriched. Previous studies have utilized rodents (rats and mice) a s experimental models to study the dyslipoproteinemia induced by S. ma nsoni infection. However, the plasma lipoprotein profiles in these ani mals is very different from humans and infection is not accompanied by decreases in LCAT activity or cholesterol enrichment of their erythro cyte membranes, Here we have evaluated the suitability of the marmoset Callithrix jacchus (sagui) which is small and readily available in Br azil, as a potential animal model for the study of the dyslipoproteine mia of S, mansoni infections. The plasma lipoprotein compositions and distributions in sagui, unlike rats or mice, approximate those of man with the LDL representing a major lipoprotein species. The molecular s pecies of phospholipids, cholesterol esters and triglycerides present in sagui plasma are also very similar to man, whereas those of rats an d mice favor the longer chain more unsaturated species. Sagui, like ro dents, can be successfully infected with S. mansoni and after 60 days, this results in a 50% reduction in plasma LCAT activity, an 11% reduc tion in plasma cholesterol esters, an absolute increase of 46% in plas ma phospholipids and an 18% increase in the cholesterol content of ery throcyte membranes. These changes are qualitatively and quantitatively very similar to those previously reported following human infections. Based upon these changes, and the observation that the plasma lipopro tein profile of sagui and human is similar, we conclude that C. jacchu s (sagui) is an appropriate animal model for the study of dyslipoprote inemia associated with S. mansoni infections. (C) 1998 Elsevier Scienc e B,V. All rights reserved.